Gencurix Inc. (KOSDAQ: 229000)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,458.00
+2.00 (0.14%)
Dec 19, 2024, 1:53 PM KST

Gencurix Company Description

Gencurix Inc. provides diagnostic solutions in South Korea.

Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection.

The company was founded in 2011 and is headquartered in Seoul, South Korea.

Gencurix Inc.
Country South Korea
Founded 2011
Industry In Vitro and In Vivo Diagnostic Substances
CEO Sung-Rai Cho

Contact Details

Address:
Hanhwa Bizmetro
Seoul, 152-733
South Korea
Phone 82 2 2621 7038
Website gencurix.com

Stock Details

Ticker Symbol 229000
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 2835

Key Executives

Name Position
Sung-Rai Cho Chief Executive Officer